Theriva Biologics implements a robust digital strategy to centralize clinical trial insights and streamline regulatory submissions. This approach integrates complex data streams across research, development, and compliance workflows to accelerate therapeutic development. The company specifically focuses on modernizing its data management and regulatory processes within the biotechnology landscape.
This transformation creates critical dependencies on data integrity, system interoperability, and automated workflow reliability. It introduces challenges such as data synchronization failures, regulatory submission bottlenecks, and system integration gaps. This page analyzes Theriva Biologics’s specific digital initiatives, the operational challenges they face, and potential opportunities for sales engagement.
Theriva Biologics Snapshot
Headquarters: Rockville, Maryland
Number of employees: 16 employees
Public or private: Public
Business model: B2B
Website: http://www.therivabio.com
Theriva Biologics ICP and Buying Roles
Theriva Biologics sells to organizations managing complex drug development pipelines and clinical research.
- Pharmaceutical companies
- Biotechnology firms
- Contract Research Organizations
Who drives buying decisions
-
Chief Scientific Officer (CSO) → Directs research strategy and technology adoption.
-
Head of Clinical Operations → Oversees clinical trial execution and data management systems.
-
VP of Regulatory Affairs → Manages regulatory submissions and compliance technology.
-
Head of R&D IT → Implements and maintains scientific computing and data infrastructure.
Key Digital Transformation Initiatives at Theriva Biologics (At a Glance)
-
Integrating disparate clinical data sources into a unified clinical data platform.
-
Automating regulatory document generation, review, and submission workflows.
-
Digitalizing pharmacovigilance case intake, assessment, and reporting.
-
Establishing a centralized research data repository for preclinical studies.
Where Theriva Biologics’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Data Integration Platforms | Clinical Trial Data Streamlining: patient data fails to consolidate across eCRF and lab systems. | Head of Clinical Operations, Head of R&D IT | Integrate diverse clinical data sources into a single, cohesive view. |
| Clinical Trial Data Streamlining: discrepancies appear when merging data from multiple sites. | Head of Clinical Operations, Data Manager | Validate incoming data for consistency and accuracy before unification. | |
| Clinical Trial Data Streamlining: reporting on trial progress experiences delays due to fragmented data access. | CSO, Head of Clinical Operations | Standardize data models to enable real-time analysis and reporting. | |
| Regulatory Information Management (RIM) Systems | Regulatory Document Lifecycle Automation: submission documents contain outdated information before final review. | VP of Regulatory Affairs, Regulatory Operations Manager | Enforce version control and content validation within submission workflows. |
| Regulatory Document Lifecycle Automation: approval routing blocks document progression for agency submissions. | VP of Regulatory Affairs, Quality Assurance Lead | Route documents based on predefined approval hierarchies without manual intervention. | |
| Regulatory Document Lifecycle Automation: tracking document status across different regulatory bodies becomes inconsistent. | VP of Regulatory Affairs, Regulatory Operations Manager | Centralize regulatory artifacts and submission tracking for global compliance. | |
| Pharmacovigilance (PV) Solutions | Pharmacovigilance Case Processing Digitalization: adverse event reports fail to transfer from intake to safety database. | Head of Drug Safety, Pharmacovigilance Lead | Prevent data loss between initial report capture and safety system ingestion. |
| Pharmacovigilance Case Processing Digitalization: duplicate cases enter the safety system requiring manual de-duplication. | Head of Drug Safety, Data Quality Analyst | Detect and merge duplicate adverse event reports upon entry. | |
| Research Data Management Systems | Research Data Repository Establishment: experimental results from various lab instruments do not integrate into the central archive. | Head of Research, Lab Operations Manager | Integrate diverse instrument outputs into a standardized data model. |
| Research Data Repository Establishment: data tagging and metadata capture remain inconsistent across research projects. | Head of Research, Data Scientist | Standardize metadata definitions and enforce consistent tagging protocols. |
Identify when companies like Theriva Biologics are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Theriva Biologics’s digital transformation unique
Theriva Biologics’s digital transformation prioritizes rigorous data integrity and compliance automation due to the high-stakes nature of biologics development. Their focus extends beyond typical operational efficiency to directly support stringent regulatory requirements for clinical trials and drug safety. This approach creates heavy dependencies on precise data orchestration and verifiable audit trails throughout the entire drug lifecycle. The complexity arises from integrating highly specialized scientific data with regulatory mandates.
Theriva Biologics’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Trial Data Streamlining
What the company is doing
Theriva Biologics integrates disparate clinical data sources into a unified clinical data platform. This process combines electronic case report form (eCRF) data, laboratory results, and imaging data. This initiative aims to consolidate all patient information from ongoing clinical trials.
Who owns this
-
Head of Clinical Operations
-
Head of R&D IT
-
Clinical Data Manager
Where It Fails
-
Patient data fails to consolidate across eCRF and lab systems.
-
Discrepancies appear when merging data from multiple clinical trial sites.
-
Reporting on trial progress experiences delays due to fragmented data access.
-
Data entry errors propagate into downstream analysis before validation.
Talk track
Noticed Theriva Biologics is streamlining clinical trial data. Been looking at how some biotech teams are automatically reconciling data from different sources instead of manual cross-referencing, can share what’s working if useful.
DT Initiative 2: Regulatory Document Lifecycle Automation
What the company is doing
Theriva Biologics automates the generation, review, and submission workflows for regulatory filings. This includes documents like Investigational New Drug (IND) applications and New Drug Applications (NDA). This initiative digitalizes the entire document lifecycle, from drafting to final submission to health authorities.
Who owns this
-
VP of Regulatory Affairs
-
Regulatory Operations Manager
-
Quality Assurance Lead
Where It Fails
-
Submission documents contain outdated information before final review.
-
Approval routing blocks document progression for agency submissions.
-
Tracking document status across different regulatory bodies becomes inconsistent.
-
Version conflicts arise when multiple authors edit regulatory documents simultaneously.
Talk track
Looks like Theriva Biologics is automating regulatory document processes. Been seeing teams enforce structured content models to prevent version conflicts instead of relying on manual document control, happy to share what we’re seeing.
DT Initiative 3: Pharmacovigilance Case Processing Digitalization
What the company is doing
Theriva Biologics implements systems for electronic capture and analysis of adverse event reports. This includes intake from various sources, assessment, and reporting to regulatory authorities. This initiative centralizes and accelerates the processing of drug safety information.
Who owns this
-
Head of Drug Safety
-
Pharmacovigilance Lead
-
Medical Director
Where It Fails
-
Adverse event reports fail to transfer from intake channels to the safety database.
-
Duplicate cases enter the safety system requiring manual de-duplication.
-
Case narratives are inconsistent, complicating safety signal detection.
-
Reporting deadlines are missed due to manual data extraction for regulatory submissions.
Talk track
Saw Theriva Biologics is digitalizing pharmacovigilance case processing. Been looking at how some pharma teams are standardizing report intake fields to improve data quality instead of manual data cleaning, can share what’s working if useful.
DT Initiative 4: Research Data Repository Establishment
What the company is doing
Theriva Biologics establishes a centralized research data repository for preclinical studies. This system integrates data from diverse lab instruments, experimental protocols, and analysis platforms. This initiative aims to provide a single, searchable source for all preclinical research insights.
Who owns this
-
Head of Research
-
Data Scientist
-
Lab Operations Manager
Where It Fails
-
Experimental results from various lab instruments do not integrate into the central archive.
-
Data tagging and metadata capture remain inconsistent across research projects.
-
Researchers cannot easily locate past experimental data for new studies.
-
Data versioning issues prevent accurate tracking of experimental modifications.
Talk track
Noticed Theriva Biologics is establishing a centralized research data repository. Been seeing teams enforce metadata standards during data ingestion instead of retrospective data organization, happy to share what we’re seeing.
Who Should Target Theriva Biologics Right Now
This account is relevant for:
-
Clinical Data Management Platforms
-
Regulatory Information Management (RIM) Solutions
-
Pharmacovigilance Software Providers
-
Scientific Data Management Systems (SDMS)
-
Data Quality and Governance Platforms
-
Workflow Automation and Orchestration Tools
Not a fit for:
-
Basic CRM systems without specialized integrations
-
Generic HR and payroll software
-
Basic website builders with no integration capabilities
When Theriva Biologics Is Worth Prioritizing
Prioritize if:
-
You sell solutions for integrating disparate clinical trial data sources.
-
You sell platforms for automating regulatory document lifecycle management and compliance.
-
You sell systems that prevent data loss and ensure accuracy in adverse event reporting.
-
You sell tools for standardizing research data ingestion and metadata management.
-
You sell solutions that validate content and enforce version control in document workflows.
-
You sell platforms that detect and merge duplicate safety cases automatically.
Deprioritize if:
-
Your solution does not address any of the specific data integration or workflow failures identified above.
-
Your product is limited to basic data storage without advanced data validation or compliance features.
-
Your offering is not built for the strict regulatory environment of biopharmaceutical companies.
Who Can Sell to Theriva Biologics Right Now
Clinical Data Integration Platforms
Medidata Solutions - This company provides a unified clinical development platform for managing trials and collecting data.
Why they are relevant: Patient data fails to consolidate across eCRF and lab systems, causing reporting delays. Medidata can integrate diverse clinical data sources, ensuring a single source of truth for trial information and enabling real-time analysis.
Veeva Systems - This company offers cloud-based software for the life sciences industry, including clinical operations and data management.
Why they are relevant: Discrepancies appear when merging data from multiple clinical trial sites. Veeva can standardize data collection and provide robust data validation capabilities, preventing inconsistencies before they impact downstream processes.
Regulatory Information Management (RIM) Solutions
IQVIA RIM - This company offers a comprehensive suite of regulatory information management solutions for global compliance.
Why they are relevant: Submission documents contain outdated information and approval routing blocks document progression. IQVIA RIM can enforce version control and automate approval workflows, ensuring accurate and timely regulatory submissions.
Ennov Regulatory - This company provides integrated software solutions for regulatory affairs, quality, and clinical processes.
Why they are relevant: Tracking document status across different regulatory bodies becomes inconsistent. Ennov Regulatory can centralize regulatory artifacts and submission tracking, providing a clear overview of compliance status globally.
Pharmacovigilance Software Providers
ArisGlobal LifeSphere Safety - This company provides an end-to-end pharmacovigilance platform for adverse event management.
Why they are relevant: Adverse event reports fail to transfer from intake channels to the safety database, and duplicate cases enter the system. ArisGlobal can automate the intake process and incorporate de-duplication logic, preventing data loss and improving data quality.
Oracle Argus Safety - This company offers a comprehensive safety management and pharmacovigilance system.
Why they are relevant: Case narratives are inconsistent, complicating safety signal detection, and reporting deadlines are missed. Oracle Argus Safety can standardize case entry, streamline assessment, and automate reporting to ensure timely and consistent pharmacovigilance activities.
Scientific Data Management Systems (SDMS)
Thermo Fisher Scientific SampleManager LIMS - This company provides laboratory information management systems to manage lab operations and data.
Why they are relevant: Experimental results from various lab instruments do not integrate into the central archive. SampleManager LIMS can connect diverse lab instruments, capturing and standardizing data directly into the repository.
Dotmatics - This company offers a research and development platform for scientific data management and experimentation.
Why they are relevant: Data tagging and metadata capture remain inconsistent across research projects, making past data hard to locate. Dotmatics can enforce metadata standards and provide robust search capabilities, ensuring discoverability and reusability of research data.
Final Take
Theriva Biologics scales its clinical data integration and regulatory automation to accelerate drug development. Breakdowns are visible in data synchronization failures across clinical systems and bottlenecks in regulatory document approvals. This account is a strong fit for solutions that enforce data integrity, automate compliance workflows, and standardize scientific data management in highly regulated environments.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.